U.S. in Pact with Pfizer (PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $30.42 +1.91%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
Revenue Growth %: -4.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
Revenue Growth %: -4.7%
Join SI Premium – FREE
U.S. in Pact with Pfizer (NYSE: PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
Related: BioNTech SE (NASDAQ: BNTX)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck and Moderna report Phase 3 melanoma trial results
- Atlantic American faces Nasdaq delisting over late SEC filings
- FDA accepts Biohaven's troriluzole NDA resubmission for rare disease
Create E-mail Alert Related Categories
Corporate News, FDA, Hot FDA NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
